Gap Junctions Enhance the Antiproliferative Effect of MicroRNA-124-3p in Glioblastoma Cells

Journal of Cellular Physiology

Volumn 230, Issue 10, 2015, Pages 2476-2488

  Suzhi, Zhang ^a   Liang, Tao ^a   Yuexia, Peng ^a   Lucy, Liu ^b   Xiaoting, Hong ^a   Yuan, Zhang ^a   Qin, Wang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; CYCLIN DEPENDENT KINASE 6; MICRORNA 124; MICRORNA 124 3P; RETINOIC ACID; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MICRORNA; MIRN124 MICRORNA, HUMAN; MIRN124 MICRORNA, MOUSE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; COCULTURE; GAP JUNCTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PATCH CLAMP TECHNIQUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; GAP JUNCTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICE; MICRORNAS;

EID: 84932616410     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24982     Document Type: Article

References (69)

1. Agirre X, Vilas-Zornoza A, Jiménez-Velasco A, Martin-Subero JI, Cordeu L, Gárate L, San José-Eneriz E, Abizanda G, Rodríguez-Otero P, Fortes P, Rifón J, Bandrés E, Calasanz MJ, Martín V, Heiniger A, Torres A, Siebert R, Román-Gomez J, Prósper F. 2009. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124aregulates CDK6 expression and confers a poor prognosis in acutelymphoblastic leukemia. Cancer Res 69:4443-4453.
2. Asklund T, Appelskog IB, Ammerpohl O, Langmoen IA, Dilber MS, Aints A, Ekström TJ, Almqvist PM. 2003. Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. Exp Cell Res 284:185-195.
3. Azzam EI, de Toledo SM, Little JB. 2003. Oxidative metabolism, gap junctions and the ionizing radiation-induced bystander effect. Oncogene 22:7050-7057.
4. Bénard J, Douc-Rasy S. 2005. [Micro-RNA and oncogenesis]. Bull Cancer 92:757-762.
5. Bittman K, Owens DF, Kriegstein AR, LoTurco JJ. 1997. Cell coupling and uncoupling in the ventricular zone of developing neocortex. J Neurosci 17:7037-7044.
6. Cho WC. 2010. MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42:1273-1281.
7. Cronier L, Crespin S, Strale PO, Defamie N, Mesnil M. 2009. Gap junctions and cancer: New functions for an old story. Antioxid Redox Signal 11:323-338.
8. Cottin S, Ghani K, Caruso M. 2008. Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43. Cancer Gene Ther 15:823-831.
9. Czyz J. 2008. The stage-specific function of gap junctions during tumour genesis. Cell Mol Biol Lett 13:92-102.
10. Dbouk HA, Mroue RM, El-Sabban ME, Talhouk RS. 2009. Connexins: A myriad of functions extending beyond assembly of gap junction channels. Cell Commun Signal 10:1186-1203.
11. Deng Y, Wang CC, Choy KW, Du Q, Chen J, Wang Q, Li L, Chung TK, Tang T. 2014. Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies. Gene 538:217-227.
12. Dermietzel R, Spray DC. 1993. Gap junctions in the brain: Where, what type, how many and why?. Trends Neurosci 16:186-192.
13. el-Sabban ME, Pauli BU. 1994. Adhesion-mediated gap junctional communication between lung-metastatatic cancer cells and endothelium. Invasion Metastasis 14:164-176.
14. Enomoto T, Yamasaki H. 1984. Lack of intercellular communication between chemically transformed and surrounding nontransformed BALB/c 3T3 cells. Cancer Res 44:5200-5203.
15. Estin D, Li M, Spray D, Wu JK. 1999. Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy. Neurosurgery 44:361-368.
16. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK. 2007. Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 21:2683-2710.
17. Fu LL, Wen X, Bao JK, Liu B. 2012. MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol 44:733-736.
18. Giaume C, McCarthy KD. 1996. Control of gap-junctional communication in astrocytic networks. Trends Neurosci 19:319-325.
19. Guo L, Sun B, Sang F, Wang W, Lu Z. 2009. Haplotype distribution and evolutionary pattern of miR-17 and miR-124 families based on population analysis. PLoS ONE 4:1234-1243.
20. Goldberg GS, Bechberger JF, Naus CC. 1995. A pre-loading method of evaluating gap junctional communication by fluorescent dye transfer. Biotechniques 18:490-497.
21. Harada K, Nonaka T, Hamada N, Sakurai H, Hasegawa M, Funayama T, Kakizaki T, Kobayashi Y, Nakano T. 2009. Heavy-ion-induced bystander killing of human lung cancer cells: Role of gap junctional intercellular communication. Cancer Sci 100:684-688.
22. He B, Tong X, Wang L, Wang Q, Ye H, Liu B, Hong X, Tao L, Harris AL. 2009. Tramadol and flurbiprofen depress the cytotoxicity of cisplatin via their effects on gap junctions. Clin Cancer Res 15:5803-5810.
23. Hildebrandt-Eriksen ES, Aarup V, Persson R, Hansen HF, Munk ME, Ørum H. 2012. A locked nucleic acid oligonucleotide targeting microRNA 122 is well-tolerated in cynomolgus monkeys. Nucleic Acid Ther 22:152-161.
24. Hosoda T, Zheng H, Cabral-da-Silva M, Sanada F, Ide-Iwata N, Ogórek B, Ferreira-Martins J, Arranto C, D'Amario D, del Monte F, Urbanek K, D'Alessandro DA, Michler RE, Anversa P, Rota M, Kajstura J, Leri A. 2011. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 123:1287-1296.
25. Huang RP, Hossain MZ, Huang R, Gano J, Fan Y, Boynton AL. 2001. Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int J Cancer 92:130-138.
26. Jensen R, Glazer PM. 2004. Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions. Proc Natl Acad Sci USA 101:6134-6139.
27. Katakowski M, Buller B, Wang X, Rogers T, Chopp M. 2010. Functional MicroRNA is transferred between glioma Cells. Cancer Res 70:8259-8263.
28. Kandouz M, Batist G. 2010. Gap junctions and connexins as therapeutic targets in cancer. Expert Opin Ther Targets 14:681-692.
29. Koreen IV, Elsayed WA, Liu YJ, Harris AL. 2004. Tetracycline-regulated expression enables purification and functional analysis of recombinant connexin channels from mammalian cells. Biochem J 383:111-119.
30. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS. 2006. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24:857-864.
31. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. 2003. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9:1274-1281.
32. Krutovskikh VA, Piccoli C, Yamasaki H. 2002. Gap junction intercellular communication propagates cell death in cancerous cells. Oncogene 21:1989-1999.
33. Lee HK, Finniss S, Cazacu S, Bucris E, Ziv-Av A, Xiang C, Bobbitt K, Rempel SA, Hasselbach L, Mikkelsen T, Slavin S, Brodie C. 2013. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget 4:346-361.
34. Leithe E, Sirnes S, Omori Y, Rivedal E. 2006. Downregulation of gap junctions in cancer cells. Crit Rev Oncog 12:225-256.
35. Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT, Cao DX, Chen GQ, He JR, Zhao Q. 2013. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 34:713-722.
36. Li KK, Pang JC, Ching AK, Wong CK, Kong X, Wang Y, Zhou L, Chen Z, Ng HK. 2009. MiR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 40:1234-1243.
37. Lim PK, Bliss SA, Patel SA, Taborga M, Dave MA, Gregory LA, Greco SJ, Bryan M, Patel PS, Rameshwar P. 2011. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence inbreast cancer cells. Cancer Res 71:1550-1560.
38. Makeyev EV, Zhang J, Carrasco MA, Maniatis T. 2007. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 27:435-448.
39. Mesnil M, Yamasaki H. 2000. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: Role of gap-junctional intercellular communication. Cancer Res 60:3989-3999.
40. Musil LS, Cunningham BA, Edelman GM, Goodenough DA. 1990. Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and -deficient cell lines. J Cell Biol 111:2077-2088.
41. Nabel EG, Nabel GJ. 1994. Complex models for the study of gene function in cardiovascular biology. Annu Rev Physiol 56:741-761.
42. Nagy JI, Rash JE. 2000. Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res Brain Res Rev 32:29-44.
43. Pierson J, Hostager B, Fan R, Vibhakar R. 2008. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol 90:1-7.
44. Rakib MA, Kim YS, Jang WJ, Jang JS, Kang SJ, Ha YL. 2011. Preventive effect of t, t-conjugated linoleic acid on 12-O-tetradecanoylphorbol-13-acetate-induced inhibition of gap junctional intercellular communication in human mammary epithelial MCF-10A cells. J Agric Food Chem 59:4164-4170.
45. Ran D, Cai S, Wu H, Gu H. 2012. Di (2-ethylhexyl) phthalate modulates cholinergic mini-presynaptic transmission of projection neurons in Drosophila antennal lobe. Food Chem Toxicol 50:3291-3297.
46. Ruch RJ, Trosko JE, Madhukar BV. 2001. Inhibition of connexin43 gap junctional intercellular communication by TPA requires ERK activation. J Cell Biochem 83:163-169.
47. Robe PA, Nguyen-Khac M, Jolois O, Rogister B, Merville MP, Bours V. 2005. Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignantglioma cells. BMC Cancer 5:32-43.
48. Sáez JC, Martínez AD, Brañes MC, González HE. 1998. Regulation of gap junctions by protein phosphorylation. Braz J Med Biol Res 31:593-600.
49. Shinoura N, Chen L, Wani MA, Kim YG, Larson JJ, Warnick RE, Simon M, Menon AG, Bi WL, Stambrook PJ. 1996. Protein and messenger RNA expression of connexin43 in astrocytomas: Implications in brain tumor gene therapy. J Neurosurg 84:839-845.
50. Shi XB, Xue L, Ma AH, Tepper CG, Gandour-Edwards R, Kung HJ, deVere White RW. 2013. Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene 32:4130-4138.
51. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG. 2008. MiR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6:14-31.
52. Sin WC, Crespin S, Mesnil M. 2012. Opposing roles of connexin43 in glioma progression. Biochim Biophys Acta 1818:2058-2067.
53. Sirnes S, Kjenseth A, Leithe E, Rivedal E. 2009. Interplay between PKC and the MAP kinase pathway in Connexin43 phosphorylation and inhibition of gap junction intercellular communication. Biochem Biophys Res Commun 382:41-45.
54. Smirnova L, Gräfe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG. 2005. Regulation of miRNA expression during neural cell specification. Eur J Neurosci 21:1469-1477.
55. Söhl G, Willecke K. 2003. An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes 10:173-180.
56. Solan JL, Lampe PD. 2005. Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. Biochim Biophys Acta 1711:154-163.
57. Sosinsky GE, Nicholson BJ. 2005. Structural organization of gap junction channels. Biochim Biophys Acta 1711:99-125.
58. Tong X, Dong S, Yu M, Wang Q, Tao L. 2013. Role of heteromeric gap junctions in the cytotoxicity of cisplatin. Toxicology 310:53-60.
59. Trosko JE, Chang CC, Madhukar BV, Klaunig JE. 1990. Chemical, oncogene and growth factor inhibition gap junctional intercellular communication: An integrative hypothesis of carcinogenesis. Pathobiology 58:265-278.
60. Uchino K, Ochiya T, Takeshita F. 2013. RNAi therapeutics and applications of microRNAs in cancer treatment. Jpn J Clin Oncol 43:596-607.
61. Valiunas V, Polosina YY, Miller H, Potapova IA, Valiuniene L, Doronin S, Mathias RT, Robinson RB, Rosen MR, Cohen IS, Brink PR. 2005. Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J Physiol 568:459-468.
62. Wolvetang EJ, Pera MF, Zuckerman KS. 2007. Gap junction mediated transport of shRNA between human embryonic stem cells. Biochem Biophys Res Commun 363:610-615.
63. Wu J, Taylor RN, Sidell N. 2013. Retinoic acid regulates gap junction intercellular communication in human endometrial stromal cells through modulation of the phosphorylation status of connexin 43. J Cell Physiol 228:903-910.
64. Wu S, Lin Y, Xu D, Chen J, Shu M, Zhou Y, Zhu W, Su X, Zhou Y, Qiu P, Yan G. 2012. MiR-135a functions as a selective killer of malignant glioma. Oncogene 31:3866-3874.
65. Xia H, Cheung WK, Ng SS, Jiang X, Jiang S, Sze J, Leung GK, Lu G, Chan DT, Bian XW, Kung HF, Poon WS, Lin MC. 2012. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem 287:9962-9971.
66. Xu J, Zhao J, Evan G, Xiao C, Cheng Y, Xiao J. 2012. Circulating microRNAs: Novel biomarkers for cardiovascular diseases. J Mol Med (Berl) 90:865-875.
67. Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, Xu X, Wu J, Zhu Y, Zheng X, Luo J, Xie L. 2013. MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1. J Transl Med 11:276-289.
68. Zhao WH, Wu SQ, Zhang YD. 2013. Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L. Int J Mol Med 32:101-107.
69. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, Kung HF, Xie D. 2012. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61:278-289.